Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
基本信息
- 批准号:8247819
- 负责人:
- 金额:$ 29.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-02 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAIDS neuropathyAIDS/HIV problemActinsAddressAdhesivesAffectAnimal ModelAnimalsAntibodiesAwardBiochemicalBiologyBlood - brain barrier anatomyBrainBrain InjuriesCCL2 geneCXCL10 geneCell CommunicationCell NucleusCell physiologyCellsCellular MorphologyCellular StructuresCentral Nervous System DiseasesCoculture TechniquesCognitive deficitsComplexCytokine Inducible SH2-Containing ProteinCytoskeletonDNA BindingDNA Sequence RearrangementDementiaElectrical ResistanceEncephalitisEndothelial CellsEndotheliumEventExtravasationFamily memberFocal AdhesionsFunctional disorderGenetic TranscriptionGenomicsGliosisHIVHIV Envelope Protein gp120HIV InfectionsHIV encephalitisHIV-1HumanIL8 geneImmuneImmunohistochemistryImpaired cognitionImpairmentIn VitroIndividualInfectionInfiltrationInflammationInflammatoryInflammatory ResponseInjuryInterleukin-6Janus kinaseLaboratoriesLeadLeukocytesLifeLigandsLinkMediatingMembraneMessenger RNAMicrofilamentsMicrogliaModelingMolecularMusNOD/SCID mouseNervous System TraumaNervous system structureNeurogliaNeurologicNeuronal InjuryNeuronsNeuropathogenesisNeurotoxinsPathogenesisPathway interactionsPatientsPermeabilityPlayProteinsProteomicsResearchResearch SupportRoleSTAT1 geneSerineSignal TransductionStress FibersStructureSystemTestingTherapeuticTight JunctionsTimeTyrosineViralViral ProteinsViremiaVirusWorkabstractingadherent junctionautocrinebasebiological systemschemokinecytokineexposed human populationfludarabinein vivoinhibitor/antagonistinjuredinsightmacrophagemigrationmonocytenovelparacrinepreventprotein inhibitor of activated STAT 1receptor bindingresearch studyresponsetranscription factor
项目摘要
Abstract:
Blood-brain barrier (BBB) compromise is common in HIV-1-infected individuals and is implicated in the
pathogenesis of HIV-1-associated dementia. Breech of this barrier allows progeny virus and activated, HIV-1-
infected macrophages to infiltrate the brain, disseminate virus to perivascular macrophages and microglia.
Infected cells in the brain secrete neurotoxins that affect neuronal function and lead to cognitive impairments.
Therefore, a principal means to prevent neurological injury following HIV-1 infection is to halt BBB injury. To
accomplish this, the mechanisms through which HIV infection leads to BBB dysfunction need be elucidated.
Using a defined platform, integrating genomics, proteomics and cell biological systems, we recently
demonstrated that HIV-1-infected macrophages engage human brain microvascular endothelial cells and incite
an autocrine and paracrine cascade of pro-inflammatory cytokines and chemokines that ultimately affect the
structure and integrity of the BBB. Our preliminary work, in vitro and using brain microvessels from HIV-
infected humans, demonstrated that HIV-1-induced inflammation and injury to human brain endothelial cells
involve activation of STAT1 at serine 727. We further demonstrated that Fludarabine, a specific STAT1
inhibitor, reduced inflammation and viral infectivity, reduced viremia, gliosis and macrophage infiltration in the
brain of HIV encephalitic mice. Based on these observations, it is our hypothesis that STAT1 play a critical
role in HIV-1-induced BBB dysfunction and modulates macrophage-endothelial interactions. We
hypothesize that by affecting STAT1 pathways, BBB dysfunction can be reversed leading to protection
of the barrier's integrity. This hypothesis will be addressed in the following specific aims: in Aim 1, we will
investigate the effects of HIV-1 and viral-induced cytokines on the endothelial cytoskeleton, and decipher the
role of STAT-1 on these alterations. This is based on our preliminary observation that HIV-1-infected
macrophage inflammatory responses alter the endothelial cytoskeleton. In Aim 2, we will investigate the role of
STAT1 in endothelial cell function and endothelial-macrophage interaction in the context of HIV infection.
Finally in Aim 3, we will test our hypothesis that STAT1 mediates HIV-induced BBB injury in vivo, using an
animal model of HIV-1 encephalitis. These studies will provide insight into the mechanisms by which cytokines
and HIV transduce signals at the BBB, dysregulations that occurs in HIV infection and lead to BBB dysfunction. Relevance:
Forty-million people in the world are currently living with HIV/AIDS; and neurological complications are
common among these infected individuals. HIV infiltrates the brain damaging the brain endothelium, then
infects brain macrophages and injures neurons, resulting in cognitive deficits and sometimes dementia. The
work in this proposal will help us understand how HIV damages the brain endothelium and enters the brain,
how to prevent viral entry into the brain, and HIV-associated dementia.
抽象的:
血脑屏障 (BBB) 受损在 HIV-1 感染者中很常见,并且与
HIV-1相关痴呆的发病机制。突破这个屏障允许后代病毒和激活的 HIV-1-
感染的巨噬细胞渗入大脑,将病毒传播到血管周围的巨噬细胞和小胶质细胞。
大脑中受感染的细胞会分泌神经毒素,影响神经元功能并导致认知障碍。
因此,预防HIV-1感染后神经损伤的主要方法是阻止BBB损伤。到
为了实现这一目标,需要阐明 HIV 感染导致 BBB 功能障碍的机制。
使用定义的平台,整合基因组学、蛋白质组学和细胞生物系统,我们最近
证明 HIV-1 感染的巨噬细胞参与人脑微血管内皮细胞并煽动
促炎细胞因子和趋化因子的自分泌和旁分泌级联反应最终影响
BBB 的结构和完整性。我们的初步工作是在体外并使用来自艾滋病毒的脑微血管-
感染人类,证明 HIV-1 诱导炎症和人脑内皮细胞损伤
涉及丝氨酸 727 处 STAT1 的激活。我们进一步证明了 Fludarabine(一种特定的 STAT1)
抑制剂,减少炎症和病毒感染性,减少病毒血症、神经胶质增生和巨噬细胞浸润
HIV脑炎小鼠的大脑。基于这些观察,我们假设 STAT1 发挥着关键作用
在 HIV-1 诱导的 BBB 功能障碍中发挥作用并调节巨噬细胞-内皮相互作用。我们
假设通过影响 STAT1 通路,可以逆转 BBB 功能障碍,从而产生保护作用
屏障的完整性。这一假设将在以下具体目标中得到解决:在目标 1 中,我们将
研究 HIV-1 和病毒诱导的细胞因子对内皮细胞骨架的影响,并破译
STAT-1 在这些改变中的作用。这是基于我们的初步观察,即 HIV-1 感染者
巨噬细胞炎症反应改变内皮细胞骨架。在目标 2 中,我们将研究
HIV 感染背景下 STAT1 在内皮细胞功能和内皮-巨噬细胞相互作用中的作用。
最后,在目标 3 中,我们将使用以下方法检验我们的假设:STAT1 在体内介导 HIV 诱导的 BBB 损伤
HIV-1脑炎动物模型。这些研究将深入了解细胞因子的作用机制
HIV 会在 BBB 上转导信号,HIV 感染时会出现失调并导致 BBB 功能障碍。关联:
目前世界上有四千万人感染艾滋病毒/艾滋病;和神经系统并发症是
在这些感染者中很常见。 HIV 侵入大脑,损害脑内皮,然后
感染大脑巨噬细胞并损伤神经元,导致认知缺陷,有时甚至导致痴呆。这
该提案中的工作将帮助我们了解艾滋病毒如何损害大脑内皮并进入大脑,
如何防止病毒进入大脑以及与艾滋病毒相关的痴呆症。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cross-talk between STAT1 and PI3K/AKT signaling in HIV-1-induced blood-brain barrier dysfunction: role of CCR5 and implications for viral neuropathogenesis.
HIV-1 诱导的血脑屏障功能障碍中 STAT1 和 PI3K/AKT 信号传导之间的串扰:CCR5 的作用及其对病毒神经发病机制的影响。
- DOI:
- 发表时间:2010-11-01
- 期刊:
- 影响因子:4.2
- 作者:Yang, Bo;Singh, Sangya;Bressani, Rafael;Kanmogne, Georgette D
- 通讯作者:Kanmogne, Georgette D
Data in support of NFκB and JNK pathways involvement in TLR3-mediated HIV-1 transactivation, expression of IL-6 and transcription factors associated with HIV-1 replication.
支持 NFκB 和 JNK 通路参与 TLR3 介导的 HIV-1 反式激活、IL-6 表达和与 HIV-1 复制相关的转录因子的数据。
- DOI:
- 发表时间:2016-03
- 期刊:
- 影响因子:0
- 作者:Bhargavan, Biju;Woollard, Shawna M;Kanmogne, Georgette D
- 通讯作者:Kanmogne, Georgette D
Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.
HIV-1 B 亚型和重组 CRF02_AG 衍生的 Tat 蛋白对人脑微血管内皮细胞的不同作用:对血脑屏障功能障碍的影响。
- DOI:
- 发表时间:2014-06
- 期刊:
- 影响因子:0
- 作者:Woollard, Shawna M;Bhargavan, Biju;Yu, Fang;Kanmogne, Georgette D
- 通讯作者:Kanmogne, Georgette D
Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.
Toll 样受体 3 通过 NFκB 和 JNK 途径以及组蛋白乙酰化介导 HIV-1 反式激活,但长时间激活会抑制 Tat 和 HIV-1 复制。
- DOI:10.1016/j.cellsig.2015.11.005
- 发表时间:2016-02
- 期刊:
- 影响因子:4.8
- 作者:Bhargavan B;Woollard SM;Kanmogne GD
- 通讯作者:Kanmogne GD
HIV-1 induces cytoskeletal alterations and Rac1 activation during monocyte-blood-brain barrier interactions: modulatory role of CCR5.
HIV-1 在单核细胞-血脑屏障相互作用过程中诱导细胞骨架改变和 Rac1 激活:CCR5 的调节作用。
- DOI:
- 发表时间:2014-02-26
- 期刊:
- 影响因子:3.3
- 作者:Woollard, Shawna M;Li, Hong;Singh, Sangya;Yu, Fang;Kanmogne, Georgette D
- 通讯作者:Kanmogne, Georgette D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGETTE D. KANMOGNE其他文献
GEORGETTE D. KANMOGNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGETTE D. KANMOGNE', 18)}}的其他基金
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
通过靶向 CCR5 预防 HIV 感染中的阿尔茨海默病样脑部病变
- 批准号:
10700624 - 财政年份:2023
- 资助金额:
$ 29.11万 - 项目类别:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
通过靶向 CCR5 预防阿尔茨海默氏病,例如 HIV 感染中的脑病理学
- 批准号:
10161318 - 财政年份:2020
- 资助金额:
$ 29.11万 - 项目类别:
Preventing Alzheimer's Disease Like Brain Pathology in HIV Infection by Targeting CCR5
通过靶向 CCR5 预防阿尔茨海默病,例如 HIV 感染中的脑病理学
- 批准号:
10301369 - 财政年份:2020
- 资助金额:
$ 29.11万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8599489 - 财政年份:2012
- 资助金额:
$ 29.11万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8779742 - 财政年份:2012
- 资助金额:
$ 29.11万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8257050 - 财政年份:2012
- 资助金额:
$ 29.11万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8426089 - 财政年份:2012
- 资助金额:
$ 29.11万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
8055998 - 财政年份:2008
- 资助金额:
$ 29.11万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
7806523 - 财政年份:2008
- 资助金额:
$ 29.11万 - 项目类别:
Blood brain barrier immune compromise in NeuroAIDS
NeuroAIDS 中的血脑屏障免疫受损
- 批准号:
7619271 - 财政年份:2008
- 资助金额:
$ 29.11万 - 项目类别:
相似海外基金
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8919084 - 财政年份:2014
- 资助金额:
$ 29.11万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8701265 - 财政年份:2013
- 资助金额:
$ 29.11万 - 项目类别:
Role of Autophagy in Microglia-induced NeuroAIDS in Substance Abuse
自噬在小胶质细胞诱导的药物滥用中的神经艾滋病中的作用
- 批准号:
8584593 - 财政年份:2013
- 资助金额:
$ 29.11万 - 项目类别:
Opioid Drug abuse in the context of opportunistic infection increases susceptibil
阿片类药物滥用会增加机会性感染的易感性
- 批准号:
8485569 - 财政年份:2012
- 资助金额:
$ 29.11万 - 项目类别:
HIV Genetic Diversity and Viral Neuropathogenesis
HIV遗传多样性和病毒神经发病机制
- 批准号:
8599489 - 财政年份:2012
- 资助金额:
$ 29.11万 - 项目类别: